Skip to main content

Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies

  • Chapter
  • First Online:
Twin and Higher-order Pregnancies

Abstract

Prenatal screening poses specific challenges in multiple pregnancies but is in high demand due to the increased prevalence of multiple pregnancies. Both ultrasound and biochemical screening methods are available, although they are less accurate than in singleton pregnancies. The introduction of non-invasive prenatal testing has been a big step forward with higher sensitivities and lower false-positive rates. In this chapter, we present an overview of the methods and implications of screening for aneuploidy in multiple pregnancies, which will aid in the counseling of prospective parents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abele H, Wagner P, Sonek J, Hoopmann M, Brucker S, Artunc-Ulkumen B, Kagan KO. First trimester ultrasound screening for Down syndrome based on maternal age, fetal nuchal translucency and different combinations of the additional markers nasal bone, tricuspid and ductus venosus flow. Prenat Diagn. 2015;35(12):1182–6. https://doi.org/10.1002/pd.4664. Epub 2015 Sep 7

    Article  PubMed  Google Scholar 

  2. Agarwal K, Alfirevic Z. Pregnancy loss after chorionic villus sampling and genetic amniocentesis in twin pregnancies: a systematic review. Ultrasound Obstet Gynecol. 2012;40(2):128–34.

    CAS  PubMed  Google Scholar 

  3. Audibert F, Gagnon A. No. 262-prenatal screening for and diagnosis of aneuploidy in twin pregnancies. J Obstet Gynaecol Can. 2017;39(9):e347–61. https://doi.org/10.1016/j.jogc.2017.06.015.

    Article  PubMed  Google Scholar 

  4. Bevilacqua E, Guizani M, Cos Sanchez T, Jani JC. Concerns with performance of screening for aneuploidy by cell-free DNA analysis of maternal blood in twin pregnancy. Ultrasound Obstet Gynecol. 2016;47(1):124–5. https://doi.org/10.1002/uog.14938.

    Article  CAS  PubMed  Google Scholar 

  5. Bender W, Dugoff L. Screening for aneuploidy in multiple gestations: the challenges and options. Obstet Gynecol Clin N Am. 2018;45(1):41–53. https://doi.org/10.1016/j.ogc.2017.10.004.

    Article  Google Scholar 

  6. Bianchi DW, Prosen T, Platt LD, Goldberg JD, Abuhamad AZ, Rava RP, Sehnert AJ, et al. Massively parallel sequencing of maternal plasma DNA in 113 cases of fetal nuchal cystic hygroma. Obstet Gynecol. 2013;121(5):1057–62. https://doi.org/10.1097/AOG.0b013e31828ba3d8.

    Article  CAS  PubMed  Google Scholar 

  7. Blickstein I, Verhoeven HC, Keith LG. Zygotic splitting after assisted reproduction. N Engl J Med. 1999;340:738–9.

    CAS  PubMed  Google Scholar 

  8. Boyle B, Morris JK, McConkey R, et al. Prevalence and risk of Down syndrome in monozygotic and dizygotic multiple pregnancies in Europe: implcations for prenatal screening. British J Obstet Gynecol. 2014;121:809–19.

    CAS  Google Scholar 

  9. Canick JA, Kloza EM, Lambert-Messerlian GM, Haddow JE, Ehrich M, van den Boom D, Bombard AT, Deciu C, Palomaki GE. DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations. Prenat Diagn. 2012;32:730–4.

    CAS  PubMed  Google Scholar 

  10. Chen M, Jiang F, Guo Y, Yan H, Wang J, Zhang L, Zeng X, Li S, Li Y, Li N, Zhang C, Zhu W, Du B, Wang Y, Lan Z, Luo X, Luo F, Chen D. Validation of fetal DNA fraction estimation and its application in noninvasive prenatal testing for aneuploidy detection in multiple pregnancies. Prenat Diagn. 2019;39:1273–82.

    CAS  PubMed  Google Scholar 

  11. Cheng PJ, Shaw SW, Shih JC, Soong YK. Monozygotic twins discordant for monosomy 21 detected by first trimester nuchal translucency screening. Obstet Gynecol. 2006;107:538–41.

    PubMed  Google Scholar 

  12. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet. 2001;358:1665–7.

    CAS  PubMed  Google Scholar 

  13. Cleary-Goldman J, Berkowitz RL. First trimester screening for Down syndrome in multiple pregnancy. Semin Perinatol. 2005;29:395–400.

    PubMed  Google Scholar 

  14. Cleary-Goldman J, Rebarber A, Krantz D, Hallahan T, Saltzman D. First-trimester screening with nasalbone in twins. Am J Obstet Gynecol. 2008;199(3):283.e1–3. https://doi.org/10.1016/j.ajog.2008.07.010.

    Article  Google Scholar 

  15. Cuckle H. Down’s syndrome screening in twins. J Med Screen. 1998;5:3–4.

    CAS  PubMed  Google Scholar 

  16. Dube J, Dodds L, Armson BA. Does chorionicity or zygosity predict adverse perinatal outcomes in twins? Am J Obstet Gynecol. 2002;186:579–83.

    PubMed  Google Scholar 

  17. Fosler L, Winters P, Jones KW, Curnow KJ, Sehnert AJ, Bhatt S, Platt LD. Aneuploidy screening by non-invasive prenatal testing in twin pregnancy. Ultrasound Obstet Gynecol. 2017;49(4):470–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Ge Y, Xia L, Wu Y, Cao H. Employ ductus venosus blood flow in the early detection of trisomy 21, trisomy 18 and trisomy 13. A meta-analysis. Medicine. 2019;98(12):1–6.

    Google Scholar 

  19. Galeva S, Konstantinidou L, Gil MM, Akolekar R, Nicolaides KH. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test. Ultrasound Obstet Gynecol. 2019;53(2):208–13. https://doi.org/10.1002/uog.20160. Epub 2018 Dec 7

    Article  CAS  PubMed  Google Scholar 

  20. Gil M, Quezada MS, Bregant B, et al. Cell-free DNA analysis for trisomy risk assessment in first-trimester twin pregnancies. Fetal Diagn Ther. 2014;35:204–11.

    Google Scholar 

  21. Gil MM, Galeva S, Jani J, Konstantinidou L, Akolekar R, Plana MN, Nicolaides KH. Screening for trisomies by cffDNA testing of maternal blood in twin pregnancy: update of the Fetal Medicine Foundation results and meta-analysis. Ultrasound Obstet Gynecol. 2019;53:734–42.

    CAS  PubMed  Google Scholar 

  22. Gjerris AC, Loft A, Pinborg A, et al. First trimester screening markers are altered in pregnancies conceived after IVF/ICSI. Ultrasound Obstet Gynecol. 2009;33:8–17.

    CAS  PubMed  Google Scholar 

  23. Goncé A, Borrell A, Fortuny A, Casals E, Martínez MA, Mercadé I, Cararach V, Vanrell JA. First-trimester screening for trisomy 21 in twin pregnancy: does the addition of biochemistry make an improvement? Prenat Diagn. 2005;25(12):1156–61.

    PubMed  Google Scholar 

  24. Gray KJ, Wilkins-Haug LE. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. Pediatr Radiol. 2018;48(4):461–70. https://doi.org/10.1007/s00247-017-3958-y.

    Article  PubMed  PubMed Central  Google Scholar 

  25. He M, Pepperell J, Gundogan F, De Paepe M, Maggio L, Lu S, Kostadinov S, O’Brien B, DeLaMonte S, Pinar H, Tantravahi U. Monochorionic twins discordant for mosaic trisomy 14. Am J Med Genetics. 2014;164A:1227–33.

    Google Scholar 

  26. Jenkins TM, Wapner RJ. The challenge of prenatal diagnosis in twin pregnancies. Curr Opin Obstet Gynecol. 2000;12:87–92.

    CAS  PubMed  Google Scholar 

  27. Liao H, Liu S, Wang H. Performance of non-invasive prenatal screening for fetal aneuploidy in twin pregnancies: a meta-analysis. Prenat Diagn. 2017;37(9):874–82. https://doi.org/10.1002/pd.5118.

    Article  PubMed  Google Scholar 

  28. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS. Presence of fetal DNA in maternal plasma and serum. Lancet. 1997;350(9076):485–7.

    CAS  PubMed  Google Scholar 

  29. Lo YM, Chiu RW. Prenatal diagnosis: progress through plasma nucleic acids. Nat Rev Genet. 2007;8(1):71–7.

    CAS  PubMed  Google Scholar 

  30. Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome wide genetic and mutational profile of the fetus. Sci Trans Med. 2010;2:61ra91.

    CAS  Google Scholar 

  31. Maiz N, Staboulidou I, Leal AM, Minekawa R, Nicolaides KH. Ductus venosus Doppler at 11 to 13 weeks of gestation in the prediction of outcome in twin pregnancies. Obstet Gynecol. 2009a;113(4):860–5.

    PubMed  Google Scholar 

  32. Maiz N, Valencia C, Kagan KO, Wright D. NicolaidesKH. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound Obstet Gynecol. 2009b;33(5):512–7.

    CAS  PubMed  Google Scholar 

  33. Maiz N, Nicolaides KH. Ductus venosus in the first trimester: contribution to screening of chromosomal, cardiac defects and monochorionic twin complications. Fetal Diagn Ther. 2010;28(2):65–71.

    PubMed  Google Scholar 

  34. Maron JL, Johnson KL, Bianchi DW. Cell-free fetal DNA plasma extraction and real-time polymerase chain reaction quantification. Methods Mol Med. 2007;132:51–63.

    CAS  PubMed  Google Scholar 

  35. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. Screening for chromosomal defects at 11–14 weeks: the role of ductus venosus blood flow. Ultrasound Obstet Gynecol. 1998;12:380–4.

    CAS  PubMed  Google Scholar 

  36. Matias A, Montenegro N, Blickstein I. Down syndrome screening in multiple pregnancies. Obstet Gynecol Clin N Am. 2005a;32(1):81–96.

    Google Scholar 

  37. Matias A, Ramalho C, Montenegro N. Search for hemodynamic compromise at 11-14 weeks in monochorionic twin pregnancy: is abnormal flow in the ductus venosus predictive of twin-twin transfusion syndrome? J Matern Fetal Neonatal Med. 2005b;18(2):79–86.

    PubMed  Google Scholar 

  38. Matias A, Montenegro N, Loureiro T, Cunha M, Duarte S, Freitas D, Severo M. Screening for twin-twin transfusion syndrome at 11–14 weeks of pregnancy: the key role of ductus venosus blood flow assessment. Ultrasound Obstet Gynecol. 2010;35(2):142–8.

    CAS  PubMed  Google Scholar 

  39. Matias A, Montenegro N. Ductus venosus in twins: science matters. Ultrasound Obstet Gynecol. 2016;47(6):787. https://doi.org/10.1002/uog.15927.

    Article  CAS  PubMed  Google Scholar 

  40. Mavrides E, Sairam S, Hollis B, Thilanagathan B. Screening for aneuplody in the first trimester by assessment of blood flow in the ductus venosus. BJOG. 2012;109:1015–9.

    Google Scholar 

  41. Maymon R, Dreazen E, Rozinsky S, et al. The feasibility of nuchal translucency measurement in higher order multiple gestation achieved by assisted reproduction. Hum Reprod. 1999;14:2102–5.

    CAS  PubMed  Google Scholar 

  42. Merkatz IR, Nitowsky HM, Macri JN, Johnson WE. An association between low maternal serum alfa- fetoprotein and fetal chromosomal abnormalities. Am J Obstet Gynecol. 1984;148:886–94.

    CAS  PubMed  Google Scholar 

  43. Montenegro N, Matias A, Areias JC, Castedo S, Barros H. Increased nuchal translucency: possible involvement of early cardiac failure. Ultrasound Obstet Gynecol. 1997;10:265–8.

    CAS  PubMed  Google Scholar 

  44. Neveux LM, Palomaki GE, Knight GJ, et al. Multiple marker screening for down syndrome in twin pregnancies. Prenat Diagn. 1996;16:29–34.

    CAS  PubMed  Google Scholar 

  45. Norwitz ER, McNeill G, Kalyan A, Rivers E, Ahmed E, Meng L, Vu P, Egbert M, Shapira M, Kobara K, Parmar S, Goel S, Prins SA, Aruh I, Persico N, Robins JC, Kirshon B, Demko ZP, Ryan A, Billings PR, Rabinowitz M, Benn P, Martin KA, Hedriana HL. Validation of a single-nucleotide polymorphism-based non-invasive prenatal test in twin gestations: determination of Zygosity, individual fetal sex, and fetal aneuploidy. J Clin Med. 2019;8(7):pii: E937.

    Google Scholar 

  46. Opstal DV, Srebniak M, Polak J, et al. False negative NIPT results: figures for chromosomes 13,18 and 21 based on chorionic villi results in 5967 cases and literature review. Plos One. 2016;11(1):e0146794. https://doi.org/10.1371/journal.pone.0146794.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Pittalis MC, Dalprà L, Torricelli F, Rizzo N, Nocera G, Cariati E, Santarini L, Tibiletti MG, Agosti S, Bovicelli L, et al. The predictive value of cytogenetic diagnosis after CVS based on 4860 cases with both direct and culture methods. Prenat Diagn. 1994;14(4):267–78.

    CAS  PubMed  Google Scholar 

  48. Prats P, Rodríguez I, Comas C, Puerto B. Systematic review of screening for trisomy 21 in twin pregnancies in first trimester combining nuchal translucency and biochemical markers: a meta-analysis. Prenat Diagn. 2014;34(11):1077–83.

    PubMed  Google Scholar 

  49. Quarello E, Jacquemard F, Ville Y. Screening of aneuploidies in twin pregnancies in 2016: we may miss the boat if we fail to take action. Gynecol Obstet Fertil. 2016;44(9):457–60. https://doi.org/10.1016/j.gyobfe.2016.05.010.

    Article  CAS  PubMed  Google Scholar 

  50. Qu JZZ, Leung TY, Jiang P, Liao GJW, Cheng YKY, Sun H, et al. Noninvasive prenatal determination of twin Zygosity by maternal plasma DNA analysis. Clin Chem. 2013;59:2427–35.

    Google Scholar 

  51. Rock KR, Millard S, Seravalli V, McShane C, Kearney J, Seitz E, Baschat AA, Miller JL. Discordant anomalies and karyotype in a monochorionic twin pregnancy: a call for comprehensive genetic evaluation. Ultrasound Obstet Gynecol. 2017;49:540–5.

    Google Scholar 

  52. Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH. Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Br J Obstet Gynecol. 1996;103:999–1003.

    CAS  Google Scholar 

  53. Sebire NJ, D’Ercole C, Hughes K, Carvalho M, Nicolaides KH. Increased nuchal translucency thickness at 10–14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome. Ultrasound Obstet Gynecol. 1997;10:86–9.

    CAS  PubMed  Google Scholar 

  54. Sebire NJ, Souka A, Skentou H, Geerts L, Nicolaides KH. Early prediction of severe twin-twin trasfusion syndrome. Hum Reprod. 2000;15:2008–10.

    CAS  PubMed  Google Scholar 

  55. Snijders RJM, Noble P, Sebire JN, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10–14 weeks of gestation. Lancet. 1998;351:343–6.

    Google Scholar 

  56. Sparks NT, Norton ME, Flessel M, Goldman S, Currier RJ. Observed rate of Down syndrome in twin pregnancies. Obstet Gynecol. 2016;128:1127–33.

    PubMed  Google Scholar 

  57. Spencer K, Nicolaides KH. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one stop clinic: a review of three years experience. Br J Obstet Gynecol. 2003;110:276–80.

    CAS  Google Scholar 

  58. Sperling JD, Zlatnik MG, Norton ME, Currier RJ. Pregnancy loss after amniocentesis in monochorionic and dichorionic twin pregnancies: results from a large population-based dataset. Prenat Diagn. 2019;39(10):896–900.

    CAS  PubMed  Google Scholar 

  59. Struble CA, Syngelaki A, Oliphant A, Song K, Nicolaides KH. Fetal fraction estimate in twin pregnancies using directed cell-free DNA analysis. Fetal Diagn Ther. 2014;35:199–203.

    PubMed  Google Scholar 

  60. Tsang JC, Lo YM. Circulating nucleic acids in plasma/serum. Pathology. 2007;39(2):197–207.

    CAS  PubMed  Google Scholar 

  61. Vandecruys H, Faiola S, Auer M, Sebire N, Nicolaides KH. Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness. Ultrasound Obstet Gynecol. 2005;25:551–3.

    CAS  PubMed  Google Scholar 

  62. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, Haddow JE, Knight GJ, Palomaki GE, Canick JA. Maternal serum screening for Down’s syndrome in early pregnancy. Br Med J. 1988;297:883–7.

    CAS  Google Scholar 

  63. Wald NJ, Rish S, Hackshaw AK. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn. 2003;23:588–92.

    PubMed  Google Scholar 

  64. Yu W, Lv Y, Yin S, Liu H, Li X, Liang B, Kong L, Liu C. Screening of fetal chromosomal aneuploidy diseases using non-invasive prenatal testing in twin pregnancies. Expert Rev Mol Diagn. 2019;19(2):189–96. https://doi.org/10.1080/14737159.2019.1562906.

    Article  CAS  PubMed  Google Scholar 

Key Reading

  • Bender W, Dugoff L. Screening for aneuploidy in multiple gestations: the challenges and options. Obstet Gynecol Clin North Am. 2018;45(1):41–53. https://doi.org/10.1016/j.ogc.2017.10.004.

    Article  PubMed  Google Scholar 

  • Galeva S, Konstantinidou L, Gil MM, Akolekar R, Nicolaides KH. Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test. Ultrasound Obstet Gynecol. 2019;53(2):208–13. https://doi.org/10.1002/uog.20160. Epub 2018 Dec 7

    Article  CAS  PubMed  Google Scholar 

  • Gray KJ, Wilkins-Haug LE. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening. Pediatr Radiol. 2018;48(4):461–70. https://doi.org/10.1007/s00247-017-3958-y.

    Article  PubMed  PubMed Central  Google Scholar 

  • Matias A, Montenegro N, Loureiro T, Cunha M, Duarte S, Freitas D, Severo M. Screening for twin-twin transfusion syndrome at 11-14 weeks of pregnancy: the key role of ductus venosus blood flow assessment. Ultrasound Obstet Gynecol. 2010;35(2):142–8.

    CAS  PubMed  Google Scholar 

  • Norwitz ER, McNeill G, Kalyan A, Rivers E, Ahmed E, Meng L, Vu P, Egbert M, Shapira M, Kobara K, Parmar S, Goel S, Prins SA, Aruh I, Persico N, Robins JC, Kirshon B, Demko ZP, Ryan A, Billings PR, Rabinowitz M, Benn P, Martin KA, Hedriana HL. Validation of a single-nucleotide polymorphism-based non-invasive prenatal test in twin gestations: determination of zygosity, individual fetal sex, and fetal aneuploidy. J Clin Med. 2019;8(7):937.

    CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Matias, A., Teixeira, B., Macedo, M. (2021). Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies. In: Khalil, A., Lewi, L., Lopriore, E. (eds) Twin and Higher-order Pregnancies. Springer, Cham. https://doi.org/10.1007/978-3-030-47652-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-47652-6_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-47651-9

  • Online ISBN: 978-3-030-47652-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics